首页> 外文期刊>Translational Oncology >Evaluation of Neoadjuvant Chemotherapy Response in Women with Locally Advanced Breast Cancer Using Ultrasound Elastography
【24h】

Evaluation of Neoadjuvant Chemotherapy Response in Women with Locally Advanced Breast Cancer Using Ultrasound Elastography

机译:超声弹性成像技术对局部晚期乳腺癌妇女新辅助化疗反应的评估

获取原文
获取外文期刊封面目录资料

摘要

PURPOSE:Ultrasound elastography is a new imaging technique that can be used to assess tissue stiffness. The aim of this study was to investigate the potential of ultrasound elastography for monitoring treatment response of locally advanced breast cancer patients undergoing neoadjuvant therapy.METHODS:Fifteen women receiving neoadjuvant chemotherapy had the affected breast scanned before, 1, 4, and 8 weeks following therapy initiation, and then before surgery. Changes in elastographic parameters related to tissue biomechanical properties were then determined and compared to clinical and pathologic tumor response after mastectomy.RESULTS:Patients who responded to therapy demonstrated a significant decrease (P< .05) in strain ratios and strain differences 4 weeks after treatment initiation compared to non-responding patients. Mean strain ratio and mean strain difference for responders was 81 ± 3% and 1 ± 17% for static regions of interest (ROIs) and 81 ± 3% and 6 ± 18% for dynamic ROIs, respectively. In contrast, these parameters were 102±2%, 110±17%, 101±4%, and 109±30% for non-responding patients, respectively. Strain ratio using static ROIs was found to be the best predictor of treatment response, with 100% sensitivity and 100% specificity obtained 4 weeks after starting treatment.CONCLUSIONS:These results suggest that ultrasound elastography can be potentially used as an early predictor of tumor therapy response in breast cancer patients.
机译:目的:超声弹性成像是一种新的成像技术,可用于评估组织硬度。这项研究的目的是探讨超声弹性成像技术在监测接受新辅助治疗的局部晚期乳腺癌患者的治疗反应方面的潜力。方法:十五名接受新辅助化疗的妇女在治疗前,治疗后1、4和8周进行了患处扫描开始,然后在手术前。然后确定与组织生物力学性质相关的弹性成像参数的变化,并将其与乳房切除术后的临床和病理肿瘤反应进行比较。结果:对治疗有反应的患者治疗后4周应变比和应变差异显着降低(P <.05)与无反应的病人相比对于静态关注区域(ROI),响应者的平均应变比和平均应变差分别为81±3%和1±17%,对于动态ROI为81±3%和6±18%。相反,对于无反应的患者,这些参数分别为102±2%,110±17%,101±4%和109±30%。发现使用静态ROI的应变比是治疗反应的最佳预测指标,在开始治疗4周后可获得100%的敏感性和100%的特异性。结论:这些结果表明超声弹性成像可以潜在地用作肿瘤治​​疗的早期预测指标对乳腺癌患者的反应。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号